Effect of Gemfibrozil on HDL-Associated Serum Paraoxonase Activity and Lipoprotein Profile in Patients with Hyperlipidaemia

By Paragh G.   Balogh Z.   Seres I.   Harangi M.   Boda J.   Kovacs P.  

Clinical Drug Investigation, Vol. 19, Iss. 4, 2000-04 ,pp. : 277-282

Adis International

Access to resources Recommend Favorite

Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study

By Machado-Vieira R.   Lara D.R.   Portela L.V.C.   Goncalves C.A.   Soares J.C.   Kapczinski F.   Souza D.O.  

European Neuropsychopharmacology, Vol. 12, Iss. 3, 2002-06 ,pp. : 269-272

Elsevier

Access to resources Recommend Favorite

Apolipoprotein(a) Antisense Oligonucleotides: A New Treatment Option for Lowering Elevated Lipoprotein(a)?

By  

Current Pharmaceutical Design, Vol. 23, Iss. 10, 2017-05 ,pp. : 1562-1570

Bentham Science Publishers

Access to resources Recommend Favorite

Fluoxetine treatment for weight reduction in steroid-induced obesity: a pilot study in myasthenia gravis patients

By Achiron A.   Barak Y.   Noy S.   Pinhas-Hamiel O.  

European Neuropsychopharmacology, Vol. 9, Iss. 1, 1999-01 ,pp. : 111-113

Elsevier

Access to resources Recommend Favorite

Potential Medication Problems in Older Newly Diagnosed Cancer Patients in Canada during Cancer Treatment: A Prospective Pilot Cohort Study

By Puts Martine T.E.   Monette Johanne   Girre Veronique   Costa-Lima Beatriz  

Drugs & Aging, Vol. 27, Iss. 7, 2010-07 ,pp. : 559-572

Adis International

Access to resources Recommend Favorite